NEW YORK, Aug. 3, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq:ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced financial results for the second quarter ended June 30, 2023, and highlighted recent business achievements.
Read more at prnewswire.comElevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here